Publications

5803 Results

Evolution of combined modality therapy for stage III non-small-cell lung cancer

Authors
DR Gandara;M Edelman;P Lara;P Roberts;B Leigh
Journal / Conference
Oncology 14(7)Suppl.5:35-41
Year
2000
Research Committee(s)
Lung and Melanoma
Study Number(s)
SWOG-8805, S9804

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer

Authors
SM Keller;S Adak;H Wagner;A Herskovic;R Komaki;BJ Brooks;MC Perry;RB Livingston;DH Johnson
Journal / Conference
New England Journal of Medicine 343(17):1217-1222
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

An intervention to enhance well-being in women experiencing a breast cancer recurrence.

Authors
C Gotay;C Moinpour;K Albain;S Martino;S Green;B Taylor;J Perotti;CA Coltman, Jr.
Journal / Conference
The Department of Defense Breast Cancer Research Program 2:779
Year
2000
Research Committee(s)
Breast
Study Number(s)
S9632, S9832

Selenium effects on prostate cell growth

Authors
DG Menter;AL Sabichi;SM Lippman
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention 9:1171-1182
Year
2000
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma

Authors
RI Fisher
Journal / Conference
Seminars in Oncology 27(6)Suppl.12:2-8
Year
2000
Research Committee(s)
Lymphoma

The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03

Authors
A Aref;BA Berkey;JG Schwade;J Ensley;DE Schuller;RE Haselow;TJ Ervin;GE Laramore
Journal / Conference
Int J Radiat Oncol Biol Phys 47(2):389-394
Year
2000
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Tumor suppressor gene aberrations in acute myelogenous leukemia

Authors
DL Stirewalt;JP Radich
Journal / Conference
Hematology 5:15-25
Year
2000
Research Committee(s)
Leukemia

Improved five years survival with chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: progress report.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
Annals of Oncology 11(Suppl.4):90(#403)
Year
2000
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Phase III trials in patients with advanced stage non-small cell lung cancer: the experience in North America from 1973-1994.

Authors
OS Breathnach;B Freidlin;B Conlay;MR Green;DJ Johnson;DR Gandara;M O'Connell;R Simon;BE Johnson
Journal / Conference
Lung Cancer 29(Suppl.2):20(#62)
Year
2000
Research Committee(s)
Lung

Comparison of quality of life (QLI) outcomes for two chemotherapy regimens in non-small cell lung cancer (NSCLC).

Authors
CM Moinpour;B Lyons;LC Lovato;PK Grevstad;K Kelly;J Crowley;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):34(#109)
Year
2000
Research Committee(s)
Lung